Showing results (171-180 of 444) with videos related to
Sort By:
Pageof 45
European Respiratory Review : an Official Journal of the European Respiratory Society|September 3, 2025
Air pollution and alveolar healthCarmelo Sofia, James G H Parkin, Joseph A Bell, et al.American Journal of Respiratory and Critical Care Medicine|May 13, 2022
Agent Orange Exposure and Risk of Idiopathic Pulmonary Fibrosis among U.S. VeteransBhavika Kaul, Joyce S Lee, David V Glidden, et al.Respiratory Medicine|November 26, 2016
Idiopathic interstitial pneumonia-associated pulmonary hypertension: A target for therapy?Steven D Nathan, Jürgen Behr, Vincent Cottin, et al.Chest|January 23, 2018
Air Pollution Exposure Is Associated With Lower Lung Function, but Not Changes in Lung Function, in Patients With Idiopathic Pulmonary FibrosisKerri A Johannson, Eric Vittinghoff, Julie Morisset, et al.Annals of the American Thoracic Society|March 30, 2017
Code-based Diagnostic Algorithms for Idiopathic Pulmonary Fibrosis. Case Validation and ImprovementBrett Ley, Thomas Urbania, Gail Husson, et al.The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.Pediatrics|January 4, 2007
T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infectionLuca Richeldi, Katie Ewer, Monica Losi, et al.Annals of Internal Medicine|May 6, 2004
Early diagnosis of subclinical multidrug-resistant tuberculosisLuca Richeldi, Katie Ewer, Monica Losi, et al.Cells|June 2, 2021
Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae?Elia Bari, Ilaria Ferrarotti, Laura Saracino, et al.The European Respiratory Journal|October 20, 2018
SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)Ganesh Raghu, Luca Richeldi, Bruno Crestani, et al.Pageof 45